Dr. David Shahbazian has been leadingART-Biopharma as Executive Director since its inception in 2020, specializingin Business Development, Customer Relations, Multicenter Project Management,and strategic international partnerships.

With nearly a decade of experience, Davidpreviously served as Project Director at Trans-Hit Biomarkers Inc., where hewas responsible for establishing relationships with new academic and commercialbiobanks. David has a robust scientific background in molecular oncology, whichhe developed during his postdoctoral training in the Departments ofPharmacology and Medical Oncology at Yale University (New Haven, CT, USA) andat Georgetown University Lombardi Cancer Center (Washington, DC, USA). Hisresearch focused on breast cancer, melanoma, and pancreatic ductaladenocarcinoma, particularly in the context of signal transduction andimmuno-oncology.

David's academic work has resulted in thepublication of over 20 peer-reviewed scientific research articles, invitedreviews, and book chapters. He holds a PhD in Biochemistry from McGillUniversity (Montreal, Quebec, Canada).

David is dedicated to assisting ART-Biopharma'scustomers with their most challenging requests. His motto is, "We willmake every possible effort to advance your experimentation and science, sinceprogress cannot wait!"

Dr. Eva Simone Jordan joined ART-Biopharma inMay 2024 as a Project Director, specializing in Account Management, ProjectManagement, and Strategic Partnerships.

Eva brings nearly a decade of experience, havingserved as a Senior Project Manager at Trans-Hit Biomarkers Inc. This role wasfollowed by positions as Strategic Biospecimen Sourcing Manager and Team LeadManager at Azenta Life Sciences Sample Sourcing, where she led a team ofScientific Study Managers. Eva has a robust background in biobanking, gainedfrom her time at the Nottingham Health Science Biobank, where she progressedfrom Senior Biobank Scientist to Biobank Business Manager.

She holds a PhD in Biochemistry and MolecularBiology from the University of Leicester (United Kingdom). Eva is adept atfostering client relationships, driving business growth, and enhancingstrategic planning and operational efficiency.

Dr. Titan Asatryan graduated from Yerevan StateMedical University in 2018 and subsequently served as a Military Doctor in theArmed Forces of the Republic of Armenia. From 2018 to 2021, he worked as aGeneral Practitioner (GP) with the Brigade Support Medical Company, where heheld several key positions. During this time, Dr. Asatryan went on to become adecorated war veteran and completed the Captain's Career Course at the U.S.Army Medical Center of Excellence in Texas, USA. Following this achievement, hewas promoted to the role of Brigade Surgeon.

In 2022, Dr. Asatryan joined Art-Biopharma LLCas a Project Manager. His exceptional professional and communication skillswere instrumental in establishing ART-Biopharma’s network of partnered clinicalsites in Armenia. He has managed complex biobanking studies, coordinatingefforts among multiple teams of clinical investigators. Currently, Dr. Asatryanserves as the Project Director at ART-Biopharma, based in London, UK.

As of 2024, Dr. Asatryan is also completing hispostgraduate studies towards a Master’s in Public Health (MPH) degree at King'sCollege London, UK.

Dr. Hasmik Nersoyan earned her Medical Doctordegree from Yerevan State Medical University in 2019. She later pursuedpostgraduate studies and obtained a Master's in Public Health (MPH) from thesame institution. In 2021, she completed her residency program, specializing ingastroenterology. Dr. Nersoyan has garnered valuable experience at theMikaelyan Institute of Surgery and the National Center of Oncology of Armenia,further honing her skills and deepening her passion for healthcare.

Dr. Nersoyan joined Art-Biopharma as a ProjectManager in 2023. In this role, she combines her medical expertise with projectmanagement skills, demonstrating a strong commitment to driving impactfulinternational initiatives. She plays a crucial role in advancing numerousbiomedical studies commissioned by ART-Biopharma’s pharmaceutical partners.

‍

Dr. Vahagn Beybutyan has been a Project Managerat ART-Biopharma since 2023. He earned his Doctor of Medicine degree fromYerevan State Medical University in 2020 and specialized as a vascular surgeonin 2023. His medical practice includes positions at the Ministry of Health ofArmenia, the National Center for Burns and Dermatology, and the MikaelyanInstitute of Surgery in Yerevan, Armenia.

Dr. Beybutyan’s background in both clinicalpractice and healthcare management enables him to effectively bridge the gapbetween medical practice and project management. At ART-Biopharma, he leverageshis professional skills to oversee and advance various strategic initiatives,ensuring the successful execution of pre-clinical projects. His contributionsare instrumental in fine-tuning ART-Biopharma studies that require coordinationbetween multiple stakeholders, including ethics committees, administration,sample collection/processing, and logistics.